Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 AUD | -4.42% | -4.42% | +5.88% |
04-16 | Euroz Hartleys Adjusts Argenica Therapeutics’ Price Target to AU$1.40 From AU$1.50, Keeps at Speculative Buy | MT |
04-12 | Argenica Therapeutics Raises AU$12 Million via Placement | MT |
Sales 2022 | 0.26 0.39 0.35 | Sales 2023 | 1.75 2.66 2.39 | Capitalization | 36.88M 56.15M 50.31M |
---|---|---|---|---|---|
Net income 2022 | -4M -6.09M -5.46M | Net income 2023 | -4M -6.09M -5.46M | EV / Sales 2022 | 109,850,751 x |
Net cash position 2022 | 8.91M 13.57M 12.16M | Net cash position 2023 | 9.34M 14.22M 12.74M | EV / Sales 2023 | 15,739,424 x |
P/E ratio 2022 |
-7.77
x | P/E ratio 2023 |
-6.82
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 88.43% |
1 day | -4.42% | ||
1 week | -4.42% | ||
Current month | -19.40% | ||
1 month | -16.28% | ||
3 months | -12.90% | ||
6 months | +62.41% | ||
Current year | +5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | 11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.54 | -4.42% | 353 268 |
24-04-26 | 0.565 | +0.89% | 119,835 |
24-04-24 | 0.56 | +2.75% | 108,571 |
24-04-23 | 0.545 | -3.54% | 230,154 |
24-04-22 | 0.565 | -0.88% | 316,216 |
Delayed Quote Australian S.E., April 29, 2024 at 01:54 am
More quotes1st Jan change | Capi. | |
---|---|---|
+5.88% | 45.25M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AGN Stock